Healthcare Scope 3 Emissions: Why Suppliers Must Act Now

Healthcare Scope 3 emissions are now one of the most important challenges facing healthcare providers, NHS suppliers, pharmaceutical companies, and medical device manufacturers. Although estate energy, electricity use, and direct operational emissions remain important, the largest carbon impact in healthcare is often hidden across the wider value chain. This includes medicines, medical devices, consumables, procurement, logistics, waste, patient travel, visitor travel, and supplier activity.

This means healthcare organisations cannot reach credible net zero outcomes by focusing only on buildings and energy. A serious healthcare decarbonisation strategy must begin with Scope 3 emissions because this is where much of the sector’s carbon impact is concentrated. By understanding where emissions sit across products, suppliers, clinical pathways, and service delivery, healthcare organisations can move from general sustainability reporting to practical and measurable carbon reduction.

For healthcare suppliers, Healthcare Scope 3 emissions are no longer just a reporting issue. They are becoming part of procurement readiness, customer trust, and long term competitiveness.

Executive Overview

Healthcare has a distinctive carbon profile compared with many other sectors. Direct emissions from buildings, fleet activity, heating, cooling, and electricity use are still relevant, but they do not represent the full picture. A large proportion of healthcare emissions is created outside the organisation’s direct operational boundary. These emissions are linked to purchased goods and services, medicines, medical devices, chemicals, logistics, waste treatment, staff commuting, patient travel, and visitor travel.

This creates a practical challenge for healthcare leaders. Net zero planning cannot remain only within estates, facilities, or energy management teams. It must become a wider organisational strategy that connects procurement, clinical practice, supplier engagement, product design, finance, logistics, and service redesign. Without this joined up approach, organisations may invest in visible but lower impact actions while missing the areas where the greatest reductions can be achieved.

The purpose of this white paper is to explain why healthcare Scope 3 emissions are central to decarbonisation, where the main carbon hotspots are likely to sit, and how healthcare organisations and suppliers can move from carbon reporting to practical reduction. It also considers how SustainZone can support healthcare providers, NHS suppliers, pharmaceutical companies, and medical device manufacturers with carbon measurement, hotspot analysis, reduction planning, and procurement ready evidence.

Understanding Healthcare Scope 3 emissions helps organisations move beyond general sustainability statements and focus on the parts of the value chain where the greatest carbon impact sits.

Why Healthcare Scope 3 Emissions Are Different

Healthcare decarbonisation is shaped by two important realities. The first is that supply chain emissions are unusually dominant. Every hospital, healthcare provider, pharmaceutical company, and medical device manufacturer depends on complex supply chains that include raw materials, specialist products, packaging, logistics, outsourced services, and clinical consumables. Much of the carbon impact is therefore created before a product reaches a hospital, clinic, laboratory, or patient.

The second reality is that some clinical products and gases create concentrated emissions hotspots. In healthcare, emissions are not always spread evenly across activities. A specific product type, treatment pathway, medical device, or clinical gas can represent a disproportionately large share of the footprint. This makes product level and pathway level carbon visibility especially important. Organisations need to understand not only their total footprint, but also which products, suppliers, departments, and clinical activities are responsible for the highest impact.

This is why healthcare carbon management cannot be treated as a narrow reporting exercise. Carbon accounting should support better decisions across procurement, product design, estates, clinical practice, and supplier management. Organisations that understand healthcare Scope 3 emissions early will be better positioned to reduce emissions, manage compliance risk, and respond to changing procurement expectations.

Healthcare Sub Sectors and Carbon Hotspots

NHS and wider health systems have a large proportion of emissions linked to Scope 3 activity. These emissions are strongly connected to supply chain procurement, medicines, medical equipment, chemicals, gases, outsourced services, patient travel, visitor travel, and staff commuting. This means health systems cannot rely on estate upgrades alone to achieve credible decarbonisation. Improvements such as energy efficiency, renewable electricity, heat pumps, and low carbon heating are valuable, but they do not address the full scale of the challenge.

Hospitals and care providers have a complex emissions profile because they operate energy intensive buildings while also using large volumes of specialist products, medicines, clinical gases, consumables, and equipment. A hospital’s carbon impact is shaped by both its physical estate and the way care is delivered inside that estate. Operating theatres are one example of a high impact area because they require intensive ventilation, specialist equipment, anaesthetic gases, surgical consumables, and strict clinical controls.

Medical device manufacturers often have most of their emissions within Scope 3. Their carbon footprint is heavily influenced by raw materials, electronic components, supplier manufacturing, packaging, distribution, product use, servicing, and end of life treatment. For some types of medical equipment, the emissions created during the product’s use phase can also be highly significant. This makes product design, energy efficiency, repair, refurbishment, and lifecycle data essential to any credible decarbonisation strategy.

Pharmaceutical companies also have a Scope 3 heavy emissions profile. Their emissions are often linked to active pharmaceutical ingredients, excipients, chemical inputs, contract manufacturing, packaging, cold chain logistics, and the use phase of certain products. In some cases, a single product group can create a major share of overall emissions. This shows why pharmaceutical companies need product level footprinting rather than relying only on company level carbon totals.

Where Healthcare Carbon Emissions Sit

Across healthcare, carbon emissions are often concentrated in areas that are not immediately visible to the organisation. For NHS and health systems, the most material hotspots are usually found in purchased goods and services, medicines, medical devices, chemicals, gases, and travel. This creates a strategic need to place procurement, supplier data, product level visibility, and care pathway redesign at the centre of decarbonisation.

For hospitals and care providers, emissions are typically shaped by a combination of supply chain activity, estate energy, operating theatres, anaesthetic gases, waste, and travel. This means hospitals need both estate focused and clinically focused interventions. Energy efficiency alone will not be enough if high impact products, gases, and clinical processes are not also addressed.

For medical device manufacturers, the main hotspots are usually found in materials, electronic components, supplier manufacturing, packaging, logistics, use phase energy, servicing, and end of life treatment. The strategic implication is that manufacturers need to improve product efficiency, reduce material impact, support repair and refurbishment, and provide better lifecycle data to healthcare customers.

For pharmaceutical companies, emissions are commonly concentrated in ingredients, excipients, chemical inputs, packaging, cold chain distribution, supplier manufacturing, and specific product use phases. This makes supplier engagement and product redesign essential, particularly where one product family contributes a large share of total emissions.

A Practical Method for Healthcare Decarbonisation

Healthcare organisations need a practical method that connects carbon measurement to real decision making. The first stage is to define the organisational and operational boundary clearly. This means identifying which facilities, services, departments, procurement categories, suppliers, products, travel activities, and waste streams are included. For NHS and health systems, it may also be necessary to consider whether patient and visitor travel is part of the reporting boundary.

The second stage is to collect data from both internal and external sources. This may include procurement records, utility bills, travel data, waste data, supplier questionnaires, logistics information, product specifications, and clinical activity data. In many cases, organisations will not have perfect data at the beginning. This should not prevent action, but assumptions should be clearly documented so that data quality can improve over time.

The third stage is to calculate emissions using recognised carbon accounting principles. This should not only produce a total carbon footprint, but also show which categories, suppliers, products, and activities are driving the result. It is also important to assess the quality of the underlying data. A healthcare organisation may begin with spend based estimates, but over time it should move towards supplier specific and product level data where possible.

The final stage is to turn the results into action. This is where carbon accounting becomes strategically useful. The organisation should use the results to identify hotspots, prioritise reduction measures, support procurement decisions, engage suppliers, and create evidence for reporting or tender requirements. A carbon footprint should not simply be a document that sits on a shelf. It should become a practical tool that helps the organisation decide what to reduce first, where to invest, and how to demonstrate credible progress.

Healthcare Decarbonisation Interventions That Matter Most

Product and clinical redesign are among the strongest decarbonisation levers in healthcare. In many cases, the largest reductions will not come from small operational changes, but from changing the product, material, formulation, packaging, prescribing approach, or clinical pathway. This is especially important for pharmaceutical companies and medical device manufacturers, where product design choices can shape emissions across the full lifecycle.

Anaesthetic gases are one of the clearest examples of a high impact healthcare carbon hotspot. Some gases have a very high climate impact, and leakage from gas systems can create avoidable emissions. Hospitals can reduce impact by reviewing the use of high impact anaesthetic gases, improving monitoring, identifying leaks, training clinical teams, and tracking usage by department.

Medical equipment creates emissions through manufacturing, materials, transport, use phase energy, maintenance, and disposal. For hospitals and device manufacturers, one of the most practical near term opportunities is reducing idle energy consumption. This can be addressed through energy saving modes, overnight shutdown protocols, staff training, energy monitoring, procurement standards, predictive maintenance, repair, refurbishment, and remanufacturing.

Estate decarbonisation remains important, but it should be positioned as part of a wider Scope 3 led pathway. Hospitals and healthcare facilities still need to reduce emissions from heating, cooling, lighting, ventilation, and electricity use. Measures such as heat pumps, solar panels, building energy optimisation, smart controls, low carbon heating, and renewable electricity procurement can all play an important role.

Care pathway redesign can reduce emissions while also improving patient experience and operational efficiency. In healthcare, carbon reduction should not only be about reporting. It should support better service delivery. Reducing unnecessary travel, avoiding duplicated tests, improving appointment coordination, and using remote care where clinically suitable can all reduce emissions while making the system more efficient.

Why Healthcare Organisations Need to Act Now

The healthcare sector is moving from voluntary sustainability action towards procurement linked carbon requirements. For NHS suppliers, carbon performance is becoming increasingly important for market access. Suppliers are expected to provide credible evidence of carbon measurement, reduction planning, Scope 3 understanding, and progress over time.

This creates a direct commercial risk for healthcare suppliers. Carbon reporting is no longer only about reputation or corporate responsibility. It is increasingly linked to tender eligibility, supplier selection, customer expectations, and long term competitiveness. Organisations that delay may find it harder to respond to procurement questions, provide carbon evidence, or demonstrate progress when required.

Healthcare suppliers should prepare early by developing a clear carbon inventory, understanding their Scope 3 hotspots, improving supplier data, preparing Carbon Reduction Plans, and building product level carbon evidence where relevant. Those that act early will be better positioned to meet NHS expectations, strengthen customer trust, and compete in a market where sustainability evidence is becoming part of contract readiness.

Governance Lessons for Healthcare Leaders

A strong healthcare carbon strategy should begin with a clear understanding of organisational boundaries. Leaders need to decide what is included in the footprint, including whether patient and visitor travel is part of the reporting scope. Without a clear boundary, it becomes difficult to compare results, track progress, or build confidence in the data.

The next lesson is that organisations should focus on the real hotspots rather than spreading effort evenly across every category. In healthcare, the largest emissions may sit in a small number of products, suppliers, clinical activities, or pathways. Identifying these hotspots allows organisations to focus resources where they will have the greatest effect.

Data quality should also improve over time. Many organisations will begin with estimates, but the long term direction should be towards supplier specific data, product level footprints, and better evidence for procurement decisions. This is particularly important as healthcare customers and public sector buyers ask for more detailed sustainability information.

Finally, sustainability work must be connected to procurement, clinical leadership, estates, finance, operations, and quality improvement. If carbon management sits in isolation, it is unlikely to influence the decisions that matter most. The strongest organisations will be those that turn carbon data into practical decisions about purchasing, product choice, clinical practice, service design, and investment.

How SustainZone Can Support Healthcare Scope 3 Emissions Reduction

SustainZone is well positioned to support healthcare organisations and suppliers with practical Scope 3 led decarbonisation. The strongest opportunity is to help organisations move from carbon complexity to clear, evidence based action. Many healthcare organisations know they need to reduce emissions, but they may not know where the largest impact sits, which data is required, or how to prepare evidence for procurement and reporting.

SustainZone can support healthcare providers, NHS suppliers, pharmaceutical companies, medical device manufacturers, healthcare logistics providers, and medical consumable suppliers by helping them measure emissions, identify hotspots, improve supplier data, and build credible reduction plans. This support can also help organisations prepare for NHS procurement expectations, customer due diligence, ESG reporting, and future product level carbon requirements.

The market facing message should be clear. Healthcare decarbonisation must protect patient care while making carbon visible across the supply chain, product portfolio, and care pathway. For healthcare suppliers, this is no longer only a sustainability issue. It is becoming part of contract readiness, customer trust, and long term competitiveness.

Conclusion

Healthcare Scope 3 emissions require a practical, evidence based, and value chain focused approach. The sector’s largest emissions are often hidden in supply chains, medicines, devices, logistics, gases, and care pathways rather than only in buildings. This means organisations that focus only on estate energy will miss many of the most important opportunities for reduction.

The most effective strategies will combine carbon measurement, hotspot analysis, supplier engagement, product level transparency, clinical redesign, estate improvements, and care pathway optimisation. This approach allows healthcare organisations to reduce emissions while maintaining patient safety, clinical quality, and operational resilience.

For healthcare suppliers, the direction is clear. Carbon performance is becoming part of market access. Organisations that prepare early will be better positioned to meet NHS expectations, win tenders, reduce risk, and demonstrate genuine sustainability leadership. SustainZone can play a valuable role by helping these organisations understand their emissions, build credible reduction plans, and turn sustainability requirements into practical, measurable action.